Read success stories about NRC research, and how our work contributes to the success of our clients and partners.
Type
Topic
Research Centre and program
Province
Year
Month
Select year above to see months
- Ottawa, Ontario
Research Centre: Human Health Therapeutics
Industry: Health and Bio-sciences
- Ottawa, Ontario
Research Centre: Human Health Therapeutics
Industry: Health and Bio-sciences
- Ottawa, Ontario
Research Centre: Digital Technologies, Human Health Therapeutics
Industry: Artificial Intelligence and Machine Learning, Health and Bio-sciences
- Ottawa, Ontario
Research Centre: Human Health Therapeutics, Metrology
Industry: Biopharmaceuticals
- Ottawa, Ontario
Research Centre: Advanced Electronics and Photonics, Digital Technologies, Herzberg Astronomy and Astrophysics, Human Health Therapeutics
Industry: Pharmaceutical Manufacturing, Communication Technologies, Biopharmaceuticals, Astronomy
- Ottawa, Ontario
Research Centre: Human Health Therapeutics
Industry: Health and Bio-sciences
- Ottawa, Ontario
Research Centre: Human Health Therapeutics
As the leading cause of birth defects, cytomegalovirus (CMV) affects more children than Fetal Alcohol Syndrome or Down Syndrome and infects up to 90 percent of adults worldwide. Typically unnoticed in healthy people, CMV can be life-threatening for the immunocompromised, which includes persons infected with HIV, organ transplant recipients and most commonly, newborn infants.
- Ottawa, Ontario
Research Centre: Human Health Therapeutics
The inner workings of the human brain hold mysteries that continue to challenge medical researchers and scientists around the world. One such mystery is determining how to delay the progression of brain diseases such as Alzheimers, Multiple Sclerosis (MS) and Parkinsons. Now an important Canadian research breakthrough may have found the key to slowing their spread.